Revenue
EPS
EBIT
Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: DKK
Unlock Free Earnings Estimates
6-K: Financial Report for the Period 1 January 2024 to 30 June 2024
Aug 7 06:56 ET
6-K: Novo Nordisk Stops the Ocedurenone CLARION-CKD Trial and Recognises Impairment Loss
Jun 26 13:22 ET
6-K: Financial Report for the Period 1 January 2024 to 31 March 2024
May 2 07:18 ET
Novo-Nordisk A/S | 6-K: Report of foreign private issuer (related to financial reporting)
Jan 31 07:03 ET
Read more
Updated: Oct 16, 2024
Strong Buy
Buy
Hold
Sell
No Data